Search filters

List of works by Lukas Bunse

A vaccine targeting mutant IDH1 induces antitumour immunity

scientific article published on 25 June 2014

Actively personalized vaccination trial for newly diagnosed glioblastoma

scientific article published on 19 December 2018

Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodes

scientific article published on 01 January 2021

Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas

scientific article published on 18 February 2020

High-throughput discovery of cancer-targeting TCRs

scientific article published on 06 November 2019

Intrathecal activation of CD8<sup>+</sup> memory T cells in IgG4-related disease of the brain parenchyma

scientific article published on 13 July 2021

K27M-mutant histone-3 as a novel target for glioma immunotherapy

scientific article

Nivolumab for Treatment of Progressive Multifocal Leukoencephalopathy in Sézary Syndrome

scientific article published on 09 July 2020

Perspectives of immunotherapy in isocitrate dehydrogenase-mutant gliomas

scientific article published on 01 November 2018

Proximity ligation assay evaluates IDH1R132H presentation in gliomas

scientific article

Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway

scientific article published on 5 August 2014

Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate

scientific article published on 09 July 2018

TCR validation toward gene therapy for cancer

scientific article published on 06 November 2019

The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway

scientific article published on 26 October 2015

The promises of immunotherapy in gliomas.

scientific article published on 4 October 2017

Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor

scientific article published on 09 May 2016

mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy

scientific article

Paulina is supported by:

About Paulina

Help